| Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes A Kautzky-Willer, M Krssak, C Winzer, G Pacini, A Tura, S Farhan, ... Diabetes 52 (2), 244-251, 2003 | 185 | 2003 |
| Everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents S Sorrentino, G Giustino, R Mehran, AS Kini, SK Sharma, M Faggioni, ... Journal of the American College of Cardiology 69 (25), 3055-3066, 2017 | 140 | 2017 |
| Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome S Demyanets, WS Speidl, I Tentzeris, R Jarai, KM Katsaros, S Farhan, ... PloS one 9 (4), e95055, 2014 | 139 | 2014 |
| Complementary role of copeptin and high‐sensitivity troponin in predicting outcome in patients with stable chronic heart failure I Tentzeris, R Jarai, S Farhan, T Perkmann, MA Schwarz, G Jakl, J Wojta, ... European journal of heart failure 13 (7), 726-733, 2011 | 128 | 2011 |
| Coronary calcification and long-term outcomes according to drug-eluting stent generation P Guedeney, BE Claessen, R Mehran, GS Mintz, M Liu, S Sorrentino, ... Cardiovascular Interventions 13 (12), 1417-1428, 2020 | 94 | 2020 |
| Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention P Guedeney, BE Claessen, DN Kalkman, M Aquino, S Sorrentino, ... Journal of the American College of Cardiology 73 (19), 2401-2409, 2019 | 81 | 2019 |
| Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention M Tscharre, R Herman, M Rohla, C Hauser, S Farhan, MK Freynhofer, ... Atherosclerosis 270, 173-179, 2018 | 73 | 2018 |
| Ticagrelor with or without aspirin after PCI: the TWILIGHT platelet substudy U Baber, MU Zafar, G Dangas, G Escolar, DJ Angiolillo, SK Sharma, ... Journal of the American College of Cardiology 75 (6), 578-586, 2020 | 71 | 2020 |
| Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation I Tentzeris, R Jarai, S Farhan, I Brozovic, P Smetana, A Geppert, J Wojta, ... Thrombosis and haemostasis 104 (12), 1211-1218, 2010 | 57 | 2010 |
| Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before … T Szük, M Gyöngyösi, N Homorodi, È Kristóf, C Király, IF Èdes, A Facskó, ... American heart journal 153 (2), 289-295, 2007 | 57 | 2007 |
| Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse … MK Freynhofer, I Brozovic, V Bruno, S Farhan, B Vogel, G Jakl, M Willheim, ... Thrombosis and haemostasis 106 (08), 230-239, 2011 | 54 | 2011 |
| Associations between chronic kidney disease and outcomes with use of prasugrel versus clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary … U Baber, J Chandrasekhar, S Sartori, M Aquino, AS Kini, S Kapadia, ... JACC: Cardiovascular Interventions 10 (20), 2017-2025, 2017 | 50 | 2017 |
| Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease S Farhan, R Jarai, I Tentzeris, A Kautzky-Willer, E Samaha, P Smetana, ... Clinical Research in Cardiology 101, 625-630, 2012 | 49 | 2012 |
| Gender differences in short-and long-term mortality in the Vienna STEMI registry E Piacková, B Jäger, S Farhan, G Christ, W Schreiber, F Weidinger, ... International journal of cardiology 244, 303-308, 2017 | 45 | 2017 |
| Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention M Rohla, MK Freynhofer, I Tentzeris, S Farhan, J Wojta, K Huber, ... European Heart Journal: Acute Cardiovascular Care 3 (1), 84-92, 2014 | 42 | 2014 |
| An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis S Demyanets, I Tentzeris, R Jarai, KM Katsaros, S Farhan, A Wonnerth, ... Cytokine 67 (2), 65-70, 2014 | 40 | 2014 |
| Fibrinolytic dysfunction in insulin‐resistant women with previous gestational diabetes S Farhan, C Winzer, A Tura, P Quehenberger, C Bieglmaier, OF Wagner, ... European journal of clinical investigation 36 (5), 345-352, 2006 | 40 | 2006 |
| Sex differences among patients with high risk receiving ticagrelor with or without aspirin after percutaneous coronary intervention: a subgroup analysis of the TWILIGHT … B Vogel, U Baber, DJ Cohen, S Sartori, SK Sharma, DJ Angiolillo, ... JAMA cardiology 6 (9), 1032-1041, 2021 | 39 | 2021 |
| Platelet function variability and non-genetic causes I Tentzeris, J Siller-Matula, S Farhan, R Jarai, J Wojta, K Huber Thrombosis and haemostasis 105 (S 06), S60-S66, 2011 | 38 | 2011 |
| Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation B Vogel, S Farhan, S Hahne, I Kozanli, K Kalla, MK Freynhofer, R Jarai, ... European Heart Journal: Acute Cardiovascular Care 5 (4), 347-353, 2016 | 37 | 2016 |
